CCDC167 as a potential therapeutic target and regulator of cell cycle-related networks in breast cancer

Pin-Shern Chen1, Hui-Ping Hsu2, Nam Nhut Phan3

  • 1Department of Biotechnology, Chia Nan University of Pharmacy and Science, Tainan 70101, Taiwan, Republic of China.

Aging
|January 18, 2021
PubMed

Insights

Coiled-coil domain-containing protein 167 (CCDC167) is upregulated in breast cancer, promoting tumor growth. Targeting CCDC167 may offer a new therapeutic strategy for breast cancer patients.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Breast cancer is a leading cause of new cancer cases in American women, with estrogen receptor (ER)-positive cancers playing a significant role.
  • Estrogen's crucial role in ER-positive breast cancer necessitates identifying novel therapeutic targets and understanding downstream pathways.
  • The specific role of coiled-coil domain-containing protein 167 (CCDC167) in breast cancer development and progression remained largely uncharacterized.

Purpose of the Study:

  • To investigate the role of CCDC167 in breast cancer.
  • To determine if CCDC167 expression correlates with patient prognosis.
  • To evaluate CCDC167 as a potential therapeutic target for breast cancer.

Main Methods:

  • Bioinformatics screening using multiple databases (ONCOMINE, MetaCore, IPA, Kaplan-Meier Plotter).
  • Analysis of CCDC167 expression levels in relation to breast cancer patient prognoses.
  • Experimental validation including CCDC167 knockdown and assessment of its effect on cancer cell growth and proliferation.
  • Investigation of CCDC167 expression changes in response to standard chemotherapy agents (fluorouracil, carboplatin, paclitaxel, doxorubicin) in MCF-7 cells.

Main Results:

  • CCDC167 was found to be upregulated across various tumor types.
  • High CCDC167 expression levels were significantly associated with poor prognoses in breast cancer patients.
  • Knockdown of CCDC167 suppressed aggressive breast cancer growth and proliferation.
  • Chemotherapy treatments led to decreased CCDC167 expression and suppressed MCF-7 cell growth.

Conclusions:

  • CCDC167 plays a significant role in promoting breast cancer growth and progression.
  • CCDC167 expression is a potential biomarker for predicting poor patient outcomes.
  • CCDC167 represents a promising novel therapeutic target for breast cancer treatment.

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.3K
Positive Regulator Molecules02:39

Positive Regulator Molecules

Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
6.2K
Positive Regulator Molecules01:45

Positive Regulator Molecules

To consistently produce healthy cells, the cell cycle—the process that generates daughter cells—must be precisely regulated.
119.3K
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
6.0K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.4K
Molecular Factors Affecting Cell Division01:27

Molecular Factors Affecting Cell Division

Several external and internal factors influence the initiation and inhibition of cell division. For instance, the death of nearby cells or the release of human growth hormone (hGH) promotes cell division. In contrast, lack of hGH or crowding of cells can inhibit cell division.
Several proteins function as internal regulators to ensure each cell cycle stage is completed faithfully before proceeding to the next. Regulator molecules may act directly or influence the activity or production of other...
3.6K